The Reference Image Database to Evaluate Therapy Response (RIDER) was a targeted data collection initiative used to generate an initial consensus on how to harmonize data collection and analysis for quantitative imaging methods applied to measure the response to drug or radiation therapy. The long term goal was to provide a resource...
The RIDER PHANTOM PET-CT collection consists of repeat measurement PET/CT phantom scan collections carried out under the aegis of the Society of Nuclear Medicine (SNM) to discern the uniformity of clinical imaging instrumentation at various sites. They were obtained in cooperation with SNM as a resource for increased quantitative understanding of machine acquisition, analytic reproducibility and image processing.
The...
The RIDER Phantom MRI data set contains repeat phantom studies. The phantom used for all data acquisitions was a version of the EuroSpin II Test Object 5 as distributed by Diagnostic Sonar, Ltd (Livingston, West Lothian, Scotland). The phantom was comprised of 18 25-mm doped gel filled tubes and 1 20-mm tube containing 0.25 mM GdDTPA.
Scanners evaluated:
- Scanner A – 1.5T GE 8-channel HD with BRM...
RIDER Neuro MRI contains imaging data on 19 patients with recurrent glioblastoma who underwent repeat imaging sets. These images were obtained approximately 2 days apart (with the exception of one patient, RIDER Neuro MRI-1086100996, whose images were obtained one day apart).
DCE‐MRI: All 19 patients had repeat dynamic contrast‐enhanced MRI (DCE‐MRI) datasets on the same...
The RIDER Lung PET-CT collection was shared to facilitate the RIDER PET/CT subgroup activities. The PET/CT subgroup was responsible for: (1) archiving de-identified DICOM serial PET/CT phantom and lung cancer patient data in a public database to provide a resource for the testing and development of algorithms and imaging tools used for assessing response to therapy, (2) conducting multiple serial imaging studies...
Ideally a patient’s response to neoadjuvant chemotherapy could be observed noninvasively, in the first 2-3 weeks of treatment using an imaging to provide feedback related to the effectiveness of the chosen chemotherapy regimen. This capability would permit individuation of patient care by supporting the opportunity to tailor chemotherapy to a each patient’s response. Functional diffusion mapping (fDM), now called...
Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be integrated, redistributed,...
This collection has been deprecated. Data from the collection formerly called OPC-Radiomics has been updated. The data are downloadable but no longer viewable in the Cancer Imaging Archive. Please view the RADCURE page to obtain access to the updated data: https://doi.org/10.7937/J47W-NM11.
Oropharynx...
All the images are diagnostic contrast enhanced CT scans. The images were retrospectively acquired, to ensure sufficient patient follow-up. Slice thickness is variable : between 3 and 6 mm. All images were done at diagnosis and prior to surgery. The objective of the study was to extract prognostic image features that will describe lung adenocarcinomas and will associate with overall survival.
Two CT features...